Quest Diagnostics has launched a new obstetrics laboratory test panel for screening eligible pregnant people for hepatitis C (HCV) alongside other standard laboratory tests.
The new test panel has been developed to include HCV antibody testing, based on data obtained from the company’s Health Trends study.
In the study, which was published in Obstetrics & Gynecology in June, laboratory testing of more than five million pregnant individuals revealed that less than 41% were screened for HCV last year.
